---
run_id: halo-evidence-vs-diagnosis-validation-v11-famous-sources-supplied-07
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v11
benchmark_version: halo-evidence-vs-diagnosis-validation-v11-v1
model_condition: famous_sources_supplied
run_number: 7
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 1024
seed: 702
prompt_source: condition packet (famous_sources_supplied) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 18fa1d51f6167dbbf1f7ece676734d5cdb459384bca25e1508dd96cd4745e42d
source_packet: a name-level list of famous source titles and authors, then the frozen Advisor prompt; no claims, summaries, source cards, or tension card - see run-packet.md
source_packet_sha256: 5f0d18f3e982d60319cdf56d83f5bfcb60ca486dc8eccd9dfcda42bea551750c
condition_packet_sha256: 5f0d18f3e982d60319cdf56d83f5bfcb60ca486dc8eccd9dfcda42bea551750c
output_file: model-outputs/famous_sources_supplied-07.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - famous_sources_supplied (run 07)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v11-v1`, condition `famous_sources_supplied`, run 7 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 702, on the frozen condition packet.

## Output

**Recommendation:** Commit to the **Claim File Review**.

**Why:** Harbor Claims is currently suffering from a "Halo Effect," where positive lagging indicators (expansion bookings, early renewals) are being attributed to the product’s value when they may actually be driven by temporary pricing bundles and sales narratives.

The evidence suggests a critical gap between *perceived* value (at the buyer/manager level) and *actual* utility (at the adjuster level). The "enthusiastic comments" are coming from buyers told SignalPath is the roadmap centerpiece, while front-line users—the ones who actually drive long-term retention—are abandoning the tool or using it only under managerial surveillance. The Usage Quality Sprint is too superficial (tracking events doesn't explain *why* a plan was ignored), and the Commercial Cleanroom is too risky (it tests pricing/sales tactics rather than product-market fit). The Claim File Review is the only option that provides "ground truth" by auditing whether the software's core output—the next-action plan—is actually correct, usable, and explainable. This is the only way to determine if SignalPath is a scalable asset or a "leaky bucket" that will cause massive churn once the bundle pricing expires and procurement windows close.

**The strongest reason against it:** It is a slow, manual process that provides a small sample size. While the board wants budget certainty in twelve days, this review will not provide a statistically significant "green light" for scaling across the entire customer base in that timeframe, potentially delaying aggressive growth targets.

**Observable evidence that would change my mind:** If the "regional carrier" churn (the two accounts already planning to remove SignalPath) was revealed to be caused exclusively by a known, trivial technical bug or a specific missing integration—rather than a failure of the tool's logic or explainability—I would pivot to the **Usage Quality Sprint** to accelerate scaling.
